About Catonsville Pharmacy
"An independent community full-service pharmacy."
Clinical Trials at Catonsville Pharmacy
During the past decade, Catonsville Pharmacy conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Catonsville Pharmacy
According to Clinical.Site data, the most researched conditions in "Catonsville Pharmacy" are
"Analgesia" (1 trials) and "Hypercholesterolemia" (1 trials). Many other conditions were trialed in "Catonsville Pharmacy" in a lesser frequency.
Clinical Trials Intervention Types at Catonsville Pharmacy
Most popular intervention types in "Catonsville Pharmacy" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atorvastatin calcium 10 mg" (1 trials) and "Ibuprofen 600 mg Immediate Release/Extended Release Caplet" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Catonsville Pharmacy
The vast majority of trials in "Catonsville Pharmacy" are
2 trials for "All" genders.
Clinical Trials Status at Catonsville Pharmacy
Currently, there are NaN active trials in "Catonsville Pharmacy".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Catonsville Pharmacy,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Catonsville Pharmacy, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".